| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,715 | 3,181 | 2,712 | 9,655 | | Cost of Revenue | 1,628 | 2,150 | 1,586 | 4,431 | | | Gross Profit | 1,087 | 1,031 | 1,126 | 5,224 | | | Operating Expenses | | Research Development | 91 | 333 | 93 | 94 | | Selling General and Administrative | 3,167 | 3,785 | 2,591 | 2,970 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,171) | (3,087) | (1,557) | 2,160 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,831) | (37) | (36) | 76 | | Earnings Before Interest And Taxes | (4,004) | (3,124) | (1,593) | 2,236 | | Interest Expense | 1,493 | 332 | 234 | 153 | | Income Before Tax | (5,497) | (3,456) | (1,828) | 2,082 | | Income Tax Expense | (528) | 417 | 111 | 570 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,969) | (3,873) | (1,938) | 1,513 | | | Non-recurring Events | | Discontinued Operations | (163) | (4,223) | 247 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,130) | (8,096) | (1,691) | 1,513 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,130) | ($8,096) | ($1,691) | $1,513 |
|
0.23% Nasdaq 
Income Statement
